Lynn Replogle
Senior Director, Commercial Strategy & Market Access
Veranex
Brooklyn, NY
Lynn has over 15 years of experience in clinical diagnostics, working the last seven years as a consultant to pharma and diagnostic clients focused on building out Commercial and Market Access strategies. At Veranex, Lynn is a senior leader, supporting clients in optimizing market access, commercial launch strategies, portfolio prioritization and opportunity assessments. Prior to joining Veranex, Lynn was Senior Director at Diaceutics where she led engagements with pharma clients and delivered strategic projects on market Intelligence, early development, market access, commercial launch & go-to-market strategies for both Dx and CDx tests. Before Diaceutics, Lynn led product management for a molecular diagnostic platform for infectious disease and helped build out the commercial strategy at Talis Biomedical (NASDAQ: TLIS) prior to it’s IPO. Lynn began her career at Abbott Laboratories in the Molecular Diagnostics Division in R&D and has an MBA from the University of Chicago and a B.S. in Biomedical Engineering from Georgia Tech.
The 29th Annual Executive War College will be held April 30 – May 1, 2024, at the Hyatt Regency Hotel New Orleans.
Join our carefully selected line-up of clinical laboratory and pathology leaders, along with your peers, at Executive War College — the premier conference focusing on the best ideas, newest lab technologies, and most innovative management strategies now reshaping the clinical laboratory industry!
Stay up to date on the latest news about Executive War College, confirmed speakers and topics, and related Dark Report events. Subscribe now!
WHAT OUR ATTENDEES ARE SAYING
"Thank you for the Executive War College. This year was my first opportunity to attend and I was truly impressed with how well it was run, the quality of the speakers, and the accommodations. It is easy to see why attendance is growing every year."
